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in order to obtain a more complete picture
of this complex phenomenon.
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The genes involved in the cellular response to DNA damage are crucial for ensuring DNA integrity during
spermatogenesis. In this issue of Cell Stem Cell, Takubo et al. (2008) show that ATM, a key kinase of the
DNA damage response, is also involved in maintaining the stem cell potential of undifferentiated
spermatogonia.The main function of the germinal lineage
is to maintain the integrity of the genome
in order to prevent reproduction failure
and to limit hereditary risk when transmit-
ted to progeny. DNA damage responses
involve the survey of DNA, and repair of
damage using signal transduction path-
ways that regulate cell-cycle checkpoints
and/or apoptosis to eliminate unrepaired
DNA-damaged cells. Defects in the DNA
damage response are the hallmarks of
cancers, premature aging syndromes,
abnormal development, and meiosis
impairment. All cells are subject to endog-
enous and exogenous genotoxic stress,
but the DNA damage response is particu-
larly important for stem cells in order to
maintain the stability of their genome
throughout the adult life of the organism,
as demonstrated for hematopoietic stem
cells (reviewed in Kenyon and Gerson,
2007). This importance is underscored
in germline stem (GS) cells due to their
dual function as stem cells and as the
guardians of the integrity of the heritable108 Cell Stem Cell 2, February 2008 ª2008genome. In this issue, Takubo et al.
(2008) show that ataxia telangiectasia-
mutated (ATM), a central protein of the
DNA damage response, regulates the
maintenance of the stem cell potential
of undifferentiated spermatogonia in
testis.
Spermatogenesis is a step-wise process
that requires coordination of mitosis, meio-
sis, and spermiogenesis, the process by
which haploid spermatids mature into
sperm. In an adult mouse testis, there are
3000–4000 GS cells—also called Asingle
(As) spermatogonia. These stem cells can
self-renew or differentiate into committed
paired (Ap) and aligned (Aal) spermatogo-
nia, which will in turn pursue their differen-
tiation processes. GS cells and committed
Ap and Aal spermatogonia are collectively
called undifferentiated spermatogonia.
The presence of GS cells in testes was
clearly demonstrated by recovery of sper-
matogenesis after transplantation of donor
testicular cells into the testis of sterile male
mice, and the reconstituting colony-form-Elsevier Inc.ing activity was found in the undifferenti-
ated spermatogonial population (Shino-
hara et al., 2000). Nakagawa et al. (2007)
recently suggested, however, that the
immediate descendants of the GS cells,
i.e., committed Ap spermatogonia, could
also retain colony-forming activity after
transplantation, introducing the notion
that these early progenitors could act as
‘‘potential stem cells.’’
ATM, a protein kinase of the phosphati-
dyl-inositol 3-kinase family, is activated
by DNA double-strand breaks, where-
upon it phosphorylates key substrates
such as p53 and Chk2, which regulate
cell-cycle checkpoints, DNA repair, and
apoptosis. Ataxia-telangiectasia (AT) pa-
tients, in which Atm is inactivated, are
characterized by a progressive cerebellar
ataxia, oculocutaneous telangiectasia,
immune deficiency, premature aging,
increased risks of lymphoma, and go-
nadal atrophy. ATM is also involved in
hematopoietic stem cell defects (Ito
et al., 2004).
Cell Stem Cell
PreviewsFigure 1. ATM and Stem Cell Self-Renewal
Atm is crucial for the maintenance of hematopoietic (HSC) and germ stem (GS) cells during aging in adult
mice, but it acts through two different pathways according to the tissue. Data are summarized from
Takubo et al. (2006, 2008) and Ito et al. (2004).In the current study, Takubo and col-
leagues (Takubo et al., 2008) investigated
the role of ATM in the maintenance of
undifferentiated spermatogonia in adult
testis. They combined several markers
and used flow cytometry to specifically
label and quantify undifferentiated sper-
matogonia (EpCAM+ a6-integrin
+ c-kit
cells) in wild-type and ATM-deficient
(Atm/) mice. They observed the progres-
sive loss of undifferentiated spermatogonia
from the Atm/ adult testis during aging.
In addition, the maintenance of spermato-
gonial cells was severely impaired during
long-term in vitro culture of cells from
Atm/ pups and also from wild-type
pups treated with caffeine, a pharmacolog-
ical inhibitor of ATM.
Next, the authors investigated the re-
constituting colony-forming activity of
adult Atm/ undifferentiated spermato-
gonia in vivo, using various testicular
transplantation assays. They confirmed
the functionality of the stem cell niche in
Atm/ testis. Most importantly, they
demonstrated the cell-autonomous de-
fect of the stem cell potential of Atm/
undifferentiated spermatogonia, although
it was difficult to quantify accurately
Atm/ donor cell colonization of recipi-
ent tubules, due to intrinsic meiotic arrest
of Atm/ cells.
Given the role of ATM in the DNA dam-
age response, Takubo and colleagues
studied the cell-cycle status and the
relative DNA damage present in Atm/
undifferentiated spermatogonia. They ob-
served a significantly higher level of DNA
damage and cell-cycle arrest in the G1
phase. They previously reported that
p16Ink4a tumor suppressorwas not upregu-
lated in Atm/ spermatogonia (Takuboet al., 2006). Now, they show that the
p19Arf-p53 tumor suppressor pathway is
activated in Atm/ undifferentiated sper-
matogonia. The p19Arf protein interacts
with MDM2 and inhibits its p53-ubiquitin
ligase activity, which results in stabilization
of p53 and, consequently, regulation of
some apoptotic and cell-cycle effectors.
Takubo et al. found that one of these effec-
tors, the cell-cycle inhibitor p21Cip1/Waf1,
was activated in Atm/ undifferentiated
spermatogonia.Remarkably, the cell-cycle
defect and the regenerative capacity after
testicular transplantation were significantly
rescued in double Atm/: p21/ mutant
mice. DNA damage and apoptotic levels
were, however, unchanged. This highlights
the role of p21 in the G1 cell-cycle arrest
of undifferentiated spermatogonia and in
exhaustion of the stem cell potential in
response to genome instability.
These new findings recall previous
studies showing that Atm/ mouse
embryo fibroblasts are defective in cellu-
lar proliferation via the p19Arf-p53-p21
pathway and exhibit premature senes-
cence (Kamijo et al., 1999), suggesting
that induction of this pathway could be
the response designed by ATM-deficient
cells in order to prevent oncogenic trans-
formation and occurrence of cancer-
prone stem cells. However, the Suda
group has previously reported a self-
renewal defect of hematopoietic stem
cells in Atm/ bone marrow, due to the
activation of a different pathway involving
oxidative stress, p16Ink4a induction, and
premature senescence (Ito et al., 2004).
Taken together, these findings illustrate,
as suggested previously, that adult stem
cells from different tissues may share
some molecular pathways, such as aCell Stem Cedependence on ATM for their mainte-
nance during aging (Figure 1). What is
more intriguing is that the same signal
transducer gene defect in stem cells can
activate different tissue-specific cas-
cades of events according to the objec-
tive of the lineage (DNA integrity for
proper heredity in the case of germ cells)
and/or the influence of specific niches
on each tissue. Hence, the global view
of stem cell regulation in the adult will
certainly turn out to be complex.
The findings of Takubo and colleagues
(Takubo et al., 2008) raise new questions
about the link between the DNA damage
response and the maintenance of GS
cells. In light of the role of the kinase
Chk2 in the ATM-p53 pathway and aging
(Cao et al., 2006), can Chk2 play a role
in the self-renewal of GS cells? Interest-
ingly, adult conditional ATM and Rad-
3-related (ATR)-deficient mice, another
key DNA damage signaling protein, also
exhibit a spermatogenesis impairment
reminiscent of GS cell defect phenotype
(Ruzankina et al., 2007). Accumulation of
DNA damage has been suggested to be
the major cause of aging, and several
lines of evidence indicate that stem cell
self-renewal may be regulated by aging-
related genes. In testis, intrinsic factors
and, most importantly, alteration of the
niche were shown to contribute to the
age-related defects of stem cell (Boyle
et al., 2007). Can aging of the niche affect
DNA repair of stem cells and their DNA
integrity, leading to activation of cell-cycle
checkpoints/apoptosis and stem cell ex-
haustion? Answers to these issues should
advance our understanding of aging and
yield useful insights for the development
of cell therapy.
REFERENCES
Boyle, M., Wong, C., Rocha, M., and Jones, D.L.
(2007). Cell Stem Cell 1, 470–478.
Cao, L., Kim, S., Xiao, C., Wang, R.H., Coumoul, X.,
Wang, X., Li, W.M., Xu, X.L., De Soto, J.A., Takai,
A., et al. (2006). EMBO J. 25, 2167–2177.
Ito, K., Hirao, A., Arai, F., Matsuoka, S., Takubo, K.,
Hamaguchi, I., Nomiyama, K., Hosokawa, K.,
Sakurada, K., Nakagata, N., et al. (2004). Nature
431, 997–1002.
Kamijo, T., van de Kamp, E., Chong, M.J., Zindy,
F., Diehl, J.A., Sherr, C.J., and McKinnon, P.J.
(1999). Cancer Res. 59, 2464–2469.
Kenyon, J., and Gerson, S.L. (2007). Nucleic Acids
Res. 35, 7557–7565.ll 2, February 2008 ª2008 Elsevier Inc. 109
Cell Stem Cell
PreviewsNakagawa, T., Nabeshima, Y., and Yoshida, S.
(2007). Dev. Cell 12, 195–206.
Ruzankina, Y., Pinzon-Guzman, C., Asare, A., Ong,
T., Pontano, L., Cotsarelis, G., Zediak, V.P., Velez,
M., Bhandoola, A., and Brown, E.J. (2007). Cell
Stem Cell 1, 113–126.Foxa2: The Rise an
Ernest Arenas1,*
1Laboratory of Molecular Neurobiology, MBB,
plan 2, Retzius building A1, 17 177 Stockholm
*Correspondence: ernest.arenas@ki.se
DOI 10.1016/j.stem.2008.01.012
Understanding the development and
cell therapies and animal models of
reveals that Foxa2 regulates dopam
spontaneously develop Parkinsonis
Progress toward the formidable goal of
developing stem cell therapies must
overcome a series of developmental and
disease-specific challenges. When con-
sidering Parkinson’s disease (PD), the
list of hurdles includes determining the
processes responsible for the normal
birth and development of dopamine (DA)
neurons, the mechanism by which this
population is selectively lost in affected
individuals, and methods to generate,
transplant, integrate, and protect replace-
ment cells in treated patients. A recent
study from the McKay lab (Kittappa
et al., 2007) demonstrates that overex-
pression of the transcription factor Foxa2
promotes the generation of DA neurons
from mouse ES cells. Moreover, deletion
of one allele of foxa2 via gene targeting re-
sults in DA cell loss and yields an animal
model of Parkinsonism.
In this study, Kittappa and colleagues
used the sonic hedgehog (shh) promoter
to map the fates of both DA and oculomo-
tor neurons. They observed that the vast
majority of DA neurons were derived
from shh-expressing progenitors in the
floor plate. Previous reports have shown
that the shh-regulated gene foxa2 is
both sufficient (Hynes et al., 1995) and
required for DA neuron development
in vivo (Ferri et al., 2007). Similarly, Kit-
tappa and colleagues noted that foxa2
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was required for the development of ven-
tral midbrain DA and oculomotor neurons
in explant cultures. Moreover, overexpres-
sion of foxa2 in progenitor and embryonic
stem cells, in the presence of Shh, fgf2,
and fgf8, increased the yield of DA neu-
rons in vitro. While a positive feedback
loop has been identified downstream of
Shh and foxa2 (Figure 1), blocking Shh sig-
naling with cyclopramine reduced the ef-
fects of foxa2 by only 50%, suggesting
that foxa2 contributes an Shh-indepen-
dent effect on DA neuron generation.
These in vitro results identify foxa2 ES
cells as an attractive candidate for cell re-
placement, but their in vitro properties re-
main to be tested. Finally, Kittappa and
collaborators also demonstrate that dele-
tion of a single allele of foxa2 results in
a valuable animal model that recapitulates
some of the features of PD. Thus the re-
cent findings from the McKay lab place
foxa2 in the center of the regenerative
medicine stage.
foxa2 at the Crossroads
of Development and Degeneration
The work by Kittappa et al. (2007) has
several important implications for the de-
velopment of cell replacement therapies
for PD (Parish and Arenas, 2007). First,
foxa2 is a strong candidate, in combination
with Shh and FGF8, for the instruction of
lsevier Inc.Biochem. Biophys. Res. Commun. 351, 993–
998.
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tiation, and that aging foxa2+/ mice
DA neuron generation. However, foxa2ap-
pears to be more than a developmental
factor, as it maintains survival of adult DA
neurons. These properties may turn out
to be particularly important when grafting
hES-derived DA neurons, which tend to
survive very poorly after transplantation.
Moreover, Shh-induced overgrowth of ES
cell-derived primitive progenitors, which
carry a risk of tumor formation in vivo,
might be avoided by relying instead on
foxa2 to generate DA neurons, as Kittappa
and colleagues observed Shh to be dis-
pensable for late stages in culture. Thus,
foxa2 expression may contribute to cir-
cumvent two of the major roadblocks
facing the use of human ES cells in trans-
plantation settings.
The findings by Kittappa and collabo-
rators may also be applied to assist in
separating DA neurons from non-DA cells
in stem cell preparations. The identifica-
tion of markers and genes that fate map
DA neurons, such as shh (Kittappa et al.,
2007), gli1, and wnt1 (Zervas et al.,
2004), together with the recent identifica-
tion of GLAST+ floor plate radial glia cells
as DA progenitors (Bonilla et al., 2008),
may allow the isolation of DA progenitors.
Similarly, growing knowledge of the
networks that regulate DA neuron devel-
opment (Figure 1 and Prakash and Wurst,
2006) may allow the direct expansion and
